These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31011676)

  • 21. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison Between Stereotactic and Conventional Radiotherapy for Solitary Lung Tumor After Resection of Lung Cancer.
    Takahashi S; Go T; Anada M; Kinoshita T; Nishide T; Yokomise H; Shibata T
    Anticancer Res; 2019 Jun; 39(6):2957-2962. PubMed ID: 31177135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid.
    Wegner RE; Abel S; Horne ZD; Hasan S; Colonias A; Verma V
    Lung Cancer Manag; 2019 Aug; 8(3):LMT14. PubMed ID: 31807142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer.
    Ma SJ; Serra LM; Bartl AJ; Han HR; Fekrmandi F; Iovoli AJ; Prezzano KM; Hermann GM; Yu H; Singh AK
    J Radiother Pract; 2022 Sep; 21(3):403-410. PubMed ID: 36016862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
    von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
    Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic body radiation therapy for prostate cancer-a review.
    Haque W; Butler EB; Teh BS
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S10. PubMed ID: 28917248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016-2018.
    Gillespie EF; Lapen K; Wang DG; Wijetunga N; Pastrana GL; Kollmeier MA; Yamada J; Schmitt AM; Higginson DS; Vaynrub M; Santos Martin E; Xu AJ; Tsai C; Yerramilli D; Cahlon O; Yang T
    Clin Transl Radiat Oncol; 2020 Nov; 25():75-80. PubMed ID: 33102818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer.
    Mitera G; Swaminath A; Rudoler D; Seereeram C; Giuliani M; Leighl N; Gutierrez E; Dobrow MJ; Coyte PC; Yung T; Bezjak A; Hope AJ
    J Oncol Pract; 2014 May; 10(3):e130-6. PubMed ID: 24643574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer-patterns of care and overall survival.
    Dohopolski MJ; Glaser SM; Vargo JA; Balasubramani GK; Beriwal S
    J Gastrointest Oncol; 2017 Oct; 8(5):766-777. PubMed ID: 29184680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.
    Chen LN; Suy S; Uhm S; Oermann EK; Ju AW; Chen V; Hanscom HN; Laing S; Kim JS; Lei S; Batipps GP; Kowalczyk K; Bandi G; Pahira J; McGeagh KG; Collins BT; Krishnan P; Dawson NA; Taylor KL; Dritschilo A; Lynch JH; Collins SP
    Radiat Oncol; 2013 Mar; 8():58. PubMed ID: 23497695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases.
    Mehta N; Zavitsanos PJ; Moldovan K; Oyelese A; Fridley JS; Gokaslan Z; Kinsella TJ; Hepel JT
    Adv Radiat Oncol; 2018; 3(3):245-251. PubMed ID: 30202794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials.
    Lehrer EJ; Kishan AU; Yu JB; Trifiletti DM; Showalter TN; Ellis R; Zaorsky NG
    Radiother Oncol; 2020 Jul; 148():235-242. PubMed ID: 32505965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
    Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
    Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
    Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
    BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High versus low dose Stereotactic Body Radiation Therapy for hepatic metastases.
    Kok END; Jansen EPM; Heeres BC; Kok NFM; Janssen T; van Werkhoven E; Sanders FRK; Ruers TJM; Nowee ME; Kuhlmann KFD
    Clin Transl Radiat Oncol; 2020 Jan; 20():45-50. PubMed ID: 31886419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir.
    Anwar M; Weinberg V; Chang AJ; Hsu IC; Roach M; Gottschalk A
    Radiat Oncol; 2014 Feb; 9():42. PubMed ID: 24484652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.
    Mercado C; Kress MA; Cyr RA; Chen LN; Yung TM; Bullock EG; Lei S; Collins BT; Satinsky AN; Harter KW; Suy S; Dritschilo A; Lynch JH; Collins SP
    Front Oncol; 2016; 6():114. PubMed ID: 27200300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body radiotherapy versus conventional radiotherapy for early-stage small cell lung cancer.
    Newman NB; Sherry AD; Byrne DW; Osmundson EC
    J Radiat Oncol; 2019 Jun; 8(2):239-248. PubMed ID: 31402969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.